Lantech Pharmaceuticals Limited

FDA inspection history across 2 sites, 2019 to 2023

2
Form 483s
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2019: one warning letter and one Form 483; 2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019One warning letter and one Form 483, at Andhra Pradesh, India and Srikakulam, India.
  2. 2019The longest 483 on file: 9 observations over 12 pages at Srikakulam, India.
  3. 2023One Form 483, at Srikakulam, India.

Cited most

Across all Lantech Pharmaceuticals Limited observations on file

The complete Lantech Pharmaceuticals Limited file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2023-09-12483 Form 483$99
2019-08-08Warning letter Warning letter$99
2019-03-15483 Form 483$99

FEI number 3012390454 · most recent document Sep 12, 2023

About Lantech Pharmaceuticals Limited

How many FDA Form 483s has Lantech Pharmaceuticals Limited received?

FDA Intel has 2 Form 483s on file for Lantech Pharmaceuticals Limited; the most recent is dated Sep 12, 2023.

When was Lantech Pharmaceuticals Limited last inspected by FDA?

The most recent FDA inspection document on file for Lantech Pharmaceuticals Limited is a Form 483 dated Sep 12, 2023, for the site in Srikakulam, India.

What did FDA cite at Lantech Pharmaceuticals Limited?

The regulations cited most in the observations on file for Lantech Pharmaceuticals Limited are 21 CFR 211.67 (Equipment cleaning and maintenance), 3 times; 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.22 (Responsibilities of quality control unit), 2 times.

Has Lantech Pharmaceuticals Limited received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Lantech Pharmaceuticals Limited; the most recent is dated Aug 8, 2019.